EU-Mercosur Trade Deal Could See Brazilian Drug Spending Soar
Executive Summary
Free trade talks between the EU and South American countries in the Mercosur trade bloc are set to resume on Nov. 6 in Brasilia. Critics of the EU proposals on intellectual property say they would mean Brazil spending billions more on medicines.
You may also be interested in...
IPR-Enhancing EU-Mercosur Trade Talks Set To Resume After Stalling
The European Commission expects talks will resume in a matter of weeks for an EU-Mercosur trade deal, which would increase intellectual property rights protection for originator medicines in the Latin American markets.
IPR-Enhancing EU-Mercosur Trade Talks Set To Resume After Stalling
The European Commission expects talks will resume in a matter of weeks for an EU-Mercosur trade deal, which would increase intellectual property rights protection for originator medicines in the Latin American markets.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.